This is a non-core endpoint: only basic statistics are computed.
See these related core endpoints for full statistics:
Use of selegiline
PDMED_SELEGILINE
No definition available.
Endpoint definition
↥Report an error or suggest an improvement for this endpoint codes
Endpoint definition steps |
FinnGen |
|---|---|
Phenotype data |
557745 |
1. Apply sex-specific ruleNone |
557745 |
2. Check conditionsNone |
557745 |
3. Check pre-conditions, main-only, mode, registry filtersRegistry filters:
1 out of 7 registries used, show all original rules. |
1958 |
4. Check minimum number of events
Min. number of events
3
|
1958 |
5. Include endpointsNone |
1958 |
6. Filter based on genotype QC (FinnGen only) |
1761 |
Control definitions (FinnGen only)
Controls for this endpoint are individuals that are not cases.
Extra metadata
- First used in FinnGen datafreeze
- DF2
Use of selegiline
based on the number of shared cases.
Similar with more cases:
Similar with less cases:
Summary Statistics
↥-FinRegistry-
This endpoint is excluded from FinRegistry analyses (omitted endpoint).
-FinnGen-
Key figures
| All | Female | Male | |
|---|---|---|---|
| Number of individuals | 1761 | 739 | 1022 |
| Unadjusted period prevalence (%) | 0.38 | 0.26 | 0.47 |
| Median age at first event (years) | 64.86 | 63.47 | 65.86 |
-FinnGen-
Age distribution of first events
-FinnGen-
Year distribution of first events
-FinnGen-
Cumulative Incidence Function
Not a core endpoint, no data to show.
CodeWAS
↥CodeWAS is a tool for exploring the associations between an endpoint and all of the medical codes and drug codes.
This is a new tool, please reach out using the contact form for feedback and improvement ideas.
First, a cohort is built by matching controls to the endpoint cases using year of birth and sex. Then, a Fisher test is done for all the medical codes and drug codes between the cases and controls of this cohort. Codes are reported in the table below if they have −log10(p-value) ≥ 6.
Matched cohort
- Matched cases
- 1799
- Matched controls
- 17990
Code
Vocabulary
Description
Odds Ratio
-log10(p)
N matched cases
N matched controls
N04BD01
ATC
selegiline; oral
+∞
307.7
1799
35
N04BA02
ATC
levodopa and decarboxylase inhibitor; oral
418.5
307.7
1611
361
N04BC09
ATC
rotigotine; transdermal
168.3
307.7
247
17
N04BB01
ATC
amantadine; oral
35.2
307.7
255
84
N04BD02
ATC
rasagiline; oral
355.3
307.7
579
24
193
Kela drug reimbursment
Rasagiline
327.8
307.7
463
19
F02.39*G20
ICD-10 Finland
Dementia in Parkinson's disease without information on additional symptoms
124.9
307.7
344
34
N04BA03
ATC
levodopa, decarboxylase inhibitor and COMT inhibitor; oral
279.9
307.7
761
47
N04BX02
ATC
entacapone; oral
255.9
307.7
299
14
N04BC04
ATC
ropinirole; oral
192.3
307.7
644
52
N04BC05
ATC
pramipexole; oral
28.4
307.7
1010
776
N87
ICPC
Parkinsonism
128.1
307.7
768
104
110
Kela drug reimbursment
Parkinson's disease and comparable movement disrorders
1016.3
307.7
1676
238
AAG20
NOMESCO Finland
Stereotactic intracranial implantation of electrodes
173.9
307.7
173
11
G20
ICD-10 Finland
Parkinson disease
771.2
307.7
1664
283
N06DA03
ATC
rivastigmine; oral, transdermal
9.2
294.4
409
560
R25.1
ICD-10 Finland
Tremor, unspecified
12.5
286.9
304
288
G25.9
ICD-10 Finland
Extrapyramidal and movement disorder, unspecified
27.4
266.6
185
75
N03AE01
ATC
clonazepam; systemic
7.6
200.2
316
492
N05AH04
ATC
quetiapine; oral
4.6
182.9
572
1653
AEA00
NOMESCO Finland
Replacement of impulse generator of stimulation device in the nervous system
43.7
178.8
107
26
AA5EN
NOMESCO Finland
Brain reseptor or transprot protein distribution isotope imaging
55.0
165.3
94
18
N04AA02
ATC
biperiden; systemic
13.6
152.0
146
116
N04BC06
ATC
cabergoline; oral
44.0
140.8
84
20
H02AA02
ATC
fludrocortisone; oral
17.3
130.4
109
67
N04BX04
ATC
opicapone; oral
158.1
126.1
132
9
AEA50
NOMESCO Finland
Adjustment of implanted neurostimulator
154.3
123.0
129
9
G04BD12
ATC
mirabegron; oral
3.7
120.0
478
1593
N19
ICPC
Speech disorder
11.9
103.5
107
95
G02CB01
ATC
bromocriptine; systemic
15.2
97.7
87
60
XA800
NOMESCO Finland
Neuropsychological investigation
6.1
91.3
167
296
G21.9
ICD-10 Finland
Secondary parkinsonism, unspecified
25.6
88.5
62
25
N04BC02
ATC
pergolide; oral
426.6
82.7
82
*
AA1BG
NOMESCO Finland
Standard MRI examination of brain with high intensity magnet
3.7
81.7
292
888
SPAT1229
SPAT
Assessment of need for aid
3.7
80.8
295
910
ZXM20
NOMESCO Finland
Intraoperative use of computerised tomography
13.2
78.0
75
59
R1250
NOMESCO Finland
Evaluation of functional capability
6.5
75.3
127
207
SPAT1224
SPAT
Implementation of speech therapy rehabilitation plan
9.2
67.4
83
94
I95.1
ICD-10 Finland
Orthostatic hypotension
4.1
64.2
190
503
C07AA05
ATC
propranolol; systemic
2.7
63.6
430
1877
R4130
NOMESCO Finland
Speech therapy
5.7
62.4
120
222
XF606
NOMESCO Finland
Ortostatic test
11.4
59.9
63
57
3320A
ICD-9 Finland
Parkinson's disease, Paralysis agitans
130.5
59.2
63
5
SPAT1220
SPAT
Assessment of need for rehabilitation and/or rehabilitation plan
3.6
58.4
211
641
F02.39
ICD-10 Finland
Dementia in Parkinson's disease without information on additional symptoms
124.1
56.2
60
5
SPAT1223
SPAT
Implementation of physical therapy rehabilitation plan
2.2
54.6
668
3768
AA1AD
NOMESCO Finland
CT of head and brain
2.1
50.8
741
4449
SPAT1215
SPAT
Assessment of need for medical rehabilitation
4.2
50.4
142
361
SPAT1230
SPAT
Aid fitting and borrowing and monitoring of use
2.4
50.4
433
2092
L28
ICPC
Limited function/disability (L)
2.3
49.6
527
2786
AA1DG
NOMESCO Finland
Very extensive MRI examination of brain with high intensity magnet
4.9
46.2
106
229
A06AD11
ATC
lactulose; oral
2.3
44.1
445
2288
Z2445
NOMESCO Finland
Psychologist
5.0
42.9
95
199
AA1CG
NOMESCO Finland
Extensive MRI examination of brain with high intensity magnet
3.0
42.8
211
769
U04
ICPC
Incontinence urine
3.1
42.6
199
704
N28
ICPC
Limited function/disability (N)
5.4
41.9
84
161
N86
ICPC
Multiple sclerosis
17.0
41.9
35
21
A28
ICPC
Limited function/disability NOS
2.1
41.9
512
2834
SPAT1231
SPAT
Assessment of adjustments needed in living environment
5.0
41.8
91
188
D21
ICPC
Swallowing problem
5.8
41.2
76
135
SPAT1216
SPAT
Assessment of functional ability
2.2
40.5
415
2138
Z00.4
ICD-10 Finland
General psychiatric examination, not elsewhere classified
3.4
40.2
156
493
R53
ICD-10 Finland
Malaise and fatigue
2.0
39.2
544
3143
R47.1
ICD-10 Finland
Dysarthria and anarthria
6.9
39.2
61
91
SPAT1295
SPAT
Other function in accordance with physical therapy nomenclature
3.4
38.2
147
462
N29
ICPC
Neurological sympt/complt other
5.3
38.2
79
156
JDB10
NOMESCO Finland
Percutaneous gastrostomy
6.8
38.0
60
91
WYA30
NOMESCO Finland
Treatment of a patient needing special arrangements
2.9
37.9
189
692
307
Kela drug reimbursment
Tacrine, donepezil, rivastigmine, galantamine and other major and expensive drugs used to treat Alzheimer's disease
3.2
37.7
161
539
W01
ICD-10 Finland
Fall on same level from slipping, tripping and stumbling
1.9
33.8
706
4636
R44.1
ICD-10 Finland
Visual hallucinations
9.7
32.5
38
40
TAW99
NOMESCO Finland
Other minor neurosurgical procedure
12.5
32.4
32
26
R5110, ,
SPAT
2.4
32.2
237
1053
KCV12
NOMESCO Finland
Urinary bladder endoscopic botulin therapy
7.7
31.9
45
60
SPAT1234
SPAT
Support of social functional capacity
2.9
31.8
162
599
SPAT1297
SPAT
Other function in accordance with speech therapy nomenclature
12.6
31.6
31
25
SPAT1226
SPAT
Implementation of occupational therapy rehabilitation plan
4.1
31.1
88
224
GD1QA
NOMESCO Finland
Supine thorax X-ray examination
1.9
30.9
504
3039
G25.2
ICD-10 Finland
Other specified forms of tremor
8.5
30.0
39
47
N39.4
ICD-10 Finland
Other specified urinary incontinence
2.4
30.0
227
1019
N05BA04
ATC
oxazepam; oral
1.9
28.7
515
3189
SPAT1137
SPAT
Taking care of patient’s/customer’s hygiene
2.5
28.6
188
790
R35
ICD-10 Finland
Polyuria
2.5
28.5
194
829
R29.8
ICD-10 Finland
Other and unspecified symptoms and signs involving the nervous and musculoskeletal systems
2.5
28.2
190
808
XXA00
NOMESCO Finland
Clinical examination requiring general anaesthesia
10.9
27.8
30
28
N04BC01
ATC
bromocriptine; oral
101.7
27.7
30
*
G35
ICD-10 Finland
Multiple sclerosis
7.1
27.2
41
59
SPAT1222
SPAT
Counselling/guidance promoting independent living
2.0
27.1
365
2051
S01.0
ICD-10 Finland
Open wound of scalp
2.3
26.8
214
982
R1260
NOMESCO Finland
Evaluation of communicative skills
4.4
26.1
66
154
M48.0
ICD-10 Finland
Spinal stenosis
2.0
25.9
314
1698
N03AX12
ATC
[U] gabapentin; oral
2.0
24.9
332
1856
N04BC07
ATC
apomorphine; parenteral
+∞
24.0
23
*
N06AX11
ATC
mirtazapine; oral
1.7
24.0
621
4239
AAW01
NOMESCO Finland
Implantation of intracranial stimulation device
+∞
23.0
22
*
SPAT1296
SPAT
Other function in accordance with occupational therapy nomenclature
5.6
22.5
43
79
N02AE01
ATC
buprenorphine; parenteral, sublingual, transdermal
1.9
22.4
346
2023
K59.09
ICD-10 Finland
Constipation, unspecified
2.3
22.4
178
814
W19
ICD-10 Finland
Unspecified fall
2.1
22.3
219
1092
M41.9
ICD-10 Finland
Scoliosis, unspecified
5.4
21.9
43
81
F0232, G20,
ICD-10 Finland
81.1
21.7
24
*
AA1CM
NOMESCO Finland
Extensive MRI examination of brain with 3 Tesla magnet
4.5
21.6
52
117
N99
ICPC
Neurological disease other
4.7
21.3
49
106
R60.0
ICD-10 Finland
Localized oedema
1.9
21.0
285
1595
G04BD09
ATC
trospium; oral
3.5
21.0
72
210
N04BX01
ATC
tolcapone; oral
+∞
20.9
20
*
AA5QN, ,
NOMESCO Finland
111.3
20.6
22
*
YX8AD
NOMESCO Finland
Stereotactic CT examination for dose design of radiotherapy
30.4
20.6
27
9
Z50.5
ICD-10 Finland
Speech therapy
5.6
20.1
38
69
S72.0
ICD-10 Finland
Fracture of neck of femur
2.5
19.9
136
581
XKD06
NOMESCO Finland
Physiologic investigation of micturition
3.0
19.8
88
301
C01CA01
ATC
etilefrine; systemic
5.9
19.7
35
60
J69.0
ICD-10 Finland
Pneumonitis due to food and vomit
3.5
19.0
66
194
R4120, ,
SPAT
4.6
19.0
45
100
F0230, G20,
ICD-10 Finland
70.6
18.7
21
*
R4110, ,
SPAT
1.9
18.7
274
1570
N06AB10
ATC
escitalopram; oral
1.8
18.3
287
1679
NA3AD
NOMESCO Finland
Lumbar spine and sacrum CT examination
3.0
17.8
79
270
N30.9
ICD-10 Finland
Cystitis, unspecified
2.3
17.7
140
637
F02.32
ICD-10 Finland
Dementia in Parkinson's disease other additional symptoms, mainly hallucinations
96.0
17.6
19
*
N30.0
ICD-10 Finland
Acute cystitis
1.8
17.6
307
1854
F02.30
ICD-10 Finland
Dementia in Parkinson's disease without additional symptoms
42.4
17.3
21
5
H50.52
ICD-10 Finland
Exophoria
5.7
17.3
32
57
R4130, ,
SPAT
14.0
17.3
29
21
R23
ICPC
Voice symptom/complaint
3.8
16.5
50
134
N31.9
ICD-10 Finland
Neuromuscular dysfunction of bladder, unspecified
5.4
16.4
32
60
G04BD11
ATC
fesoterodine; oral
3.0
16.2
71
241
NAG63
NOMESCO Finland
Posterior fusion of lumbar spine with fixation, more than 3 vertebraea
7.1
16.1
24
34
K59.0
ICD-10 Finland
Constipation
2.2
16.1
137
644
N39.0
ICD-10 Finland
Urinary tract infection, site not specified
1.7
16.0
324
2036
SPAT1221
SPAT
Guidance concerning rehabilitation services and livelihood
4.1
16.0
44
110
J01EA01
ATC
trimethoprim; systemic
1.6
15.5
458
3167
NFB20
NOMESCO Finland
Primary partial prosthetic replacement of hip joint using cement, other or unspecified
2.6
15.5
88
344
I10
ICD-10 Finland
Essential (primary) hypertension
0.7
15.4
875
10543
A03FA01
ATC
metoclopramide; systemic, rectal
0.5
15.1
145
2717
130
Kela drug reimbursment
Malignant tumour
0.3
15.0
32
1183
SPAT1217
SPAT
Assessment of need for services (elderly/care support)
1.9
14.8
190
1038
NA3AA
NOMESCO Finland
Lumbar spine X-ray examination without contrast
1.9
14.7
204
1145
NA1AD
NOMESCO Finland
Cervical spine CT examination
2.4
14.6
106
465
S01.41
ICD-10 Finland
Open wound in the temple-jaw region
4.7
14.5
33
71
S70.0
ICD-10 Finland
Contusion of hip
2.4
14.5
98
417
R32
ICD-10 Finland
Unspecified urinary incontinence
2.9
14.4
66
230
G90.3
ICD-10 Finland
Multi-system degeneration
27.4
14.3
19
7
N06BA07
ATC
modafinil; oral
42.8
14.1
17
*
NA7EA
NOMESCO Finland
Scoliosis X-ray examination
4.1
13.8
38
95
G25.8
ICD-10 Finland
Other specified extrapyramidal and movement disorders
2.8
13.7
67
242
M03BX01
ATC
baclofen; systemic
3.4
13.6
48
143
ZXM10
NOMESCO Finland
Intraoperative use of conventional X-ray imaging
2.1
13.6
125
606
C10AA05
ATC
atorvastatin; oral
0.7
13.4
517
6800
R1430, ,
SPAT
4.0
13.4
37
93
A04
ICPC
Weakness/tiredness general
1.7
13.3
290
1852
N04AA01
ATC
trihexyphenidyl; oral
40.4
13.2
16
*
G04BD08
ATC
solifenacin; oral
2.0
12.7
143
746
R1420, ,
SPAT
9.7
12.7
25
26
AA1BD
NOMESCO Finland
Extensive CT of head and brain
2.9
12.7
60
213
M80.9
ICD-10 Finland
Unspecified osteoporosis with pathological fracture
3.0
12.5
56
193
F0234, G20,
ICD-10 Finland
130.9
12.4
13
*
G25.0
ICD-10 Finland
Essential tremor
2.6
12.4
69
267
UKC02
NOMESCO Finland
Cystoscopy
1.6
12.4
356
2432
AA1AA
NOMESCO Finland
Head X-ray examination
4.7
12.4
28
60
R1250, ,
SPAT
2.7
12.3
67
257
M54.5
ICD-10 Finland
Low back pain
1.5
12.2
561
4231
L03
ICPC
Low back symptom/complaint
1.5
12.2
452
3263
T08
ICPC
Weight loss
3.3
12.2
45
138
J18.9
ICD-10 Finland
Pneumonia, unspecified
1.5
12.2
564
4260
AA1BM
NOMESCO Finland
MRI examination of brain with 3 Tesla magnet
4.4
12.2
30
69
UDQ42
NOMESCO Finland
Endoscopic assessment of swallowing function
12.5
12.1
21
17
Z03.3
ICD-10 Finland
Observation for suspected nervous system disorder
2.1
12.1
117
578
NA3BG
NOMESCO Finland
Lumbar spine MRI examination with high intensity magnet
1.8
12.1
189
1100
G04BD07
ATC
tolterodine; oral
2.1
12.0
110
532
N06AB04
ATC
citalopram; systemic
1.6
12.0
350
2397
Z02.4
ICD-10 Finland
Examination for driving licence
0.6
12.0
312
4483
Z71.3
ICD-10 Finland
Dietary counselling and surveillance
2.5
11.9
75
309
NB1AA
NOMESCO Finland
Shoulder X-ray examination without contrast
1.9
11.9
152
830
N10
ICD-10 Finland
Acute tubulo-interstitial nephritis
1.6
11.8
282
1843
PH2AE
NOMESCO Finland
Ultrasound examination of lower leg veins
1.7
11.7
222
1365
XKC03
NOMESCO Finland
Water cystometry
2.6
11.7
66
258
M41.4
ICD-10 Finland
Neuromuscular scoliosis
+∞
11.5
11
*
SPAT1156
SPAT
Guidance concerning treatment of rash and skin
1.6
11.4
264
1708
N04BA07
ATC
foslevodopa and decarboxylase inhibitor; parenteral
120.8
11.4
12
*
K02.1
ICD-10 Finland
Caries of dentine
1.4
11.4
834
6834
R44.3
ICD-10 Finland
Hallucinations, unspecified
5.4
11.4
22
41
SPAT1167
SPAT
Insertion of urinary catheter
2.3
11.3
84
373
XKD00
NOMESCO Finland
Uroflowmetry
1.5
11.3
356
2480
G04BD04
ATC
oxybutynin; oral, transdermal
2.0
11.2
121
622
R5130, ,
SPAT
9.7
11.2
22
23
KC1EE
NOMESCO Finland
Ultrasound measurement of residual urine
1.6
11.2
305
2055
R13
ICD-10 Finland
Dysphagia
1.9
11.1
145
796
C10AX09
ATC
ezetimibe; oral
0.5
11.0
125
2239
N05AH02
ATC
clozapine; systemic
4.3
11.0
28
66
K59.00
ICD-10 Finland
Constipation caused by slow bowel passage (SCT)
2.8
11.0
55
202
S40.0
ICD-10 Finland
Contusion of shoulder and upper arm
2.3
10.9
82
366
SPAT1254
SPAT
Administration of medicine
1.6
10.9
278
1842
TKC10
NOMESCO Finland
Percutaneous puncture of bladder
3.1
10.9
44
143
Z50.9
ICD-10 Finland
Care involving use of rehabilitation procedure, unspecified
2.4
10.8
76
329
Z75.5
ICD-10 Finland
Holiday relief care
3.7
10.8
34
94
R55
ICD-10 Finland
Syncope and collapse
1.7
10.7
228
1443
N31.1
ICD-10 Finland
Reflex neuropathic bladder, not elsewhere classified
4.9
10.7
23
47
J44.8
ICD-10 Finland
Other specified chronic obstructive pulmonary disease
0.4
10.7
73
1556
F02.34
ICD-10 Finland
Dementia in Parkinson's disease, other additional symptoms of mixed type
60.4
10.6
12
*
F02.31
ICD-10 Finland
Dementia in Parkinson's disease other additional symptoms, mainly paranoidism
+∞
10.4
10
*
R33
ICD-10 Finland
Retention of urine
1.7
10.4
200
1233
A06AC01
ATC
ispaghula (psylla seeds); oral
1.5
10.3
468
3503
SPAT1305
SPAT
Counselling and guidance related to physical exercise
1.8
10.1
166
978
N06AX03
ATC
mianserin; oral
2.1
10.1
93
452
E78.01
ICD-10 Finland
Pure hypercholesterolaemia
0.6
10.0
262
3787
M54.4
ICD-10 Finland
Lumbago with sciatica
1.6
10.0
270
1813
SPAT1172
SPAT
Guidance concerning hydration
2.6
9.9
55
213
NA3CG
NOMESCO Finland
Lumbar spine extensive MRI examination with high intensity magnet
2.2
9.9
78
356
M41.5
ICD-10 Finland
Other secondary scoliosis
16.8
9.9
15
9
Z50.8
ICD-10 Finland
Care involving use of other rehabilitation procedures
1.9
9.8
132
733
C08CA01
ATC
amlodipine; oral
0.7
9.7
488
6227
K08.3
ICD-10 Finland
Retained dental root
1.8
9.7
150
869
K03.66
ICD-10 Finland
Tooth plaque
1.8
9.7
134
751
L89
ICD-10 Finland
Decubitus ulcer and pressure area
2.6
9.6
54
211
C10AA07
ATC
rosuvastatin; oral
0.7
9.4
331
4515
34200
ICD-8 Finland
Paralysis agitans, Parkinsonismus
100.6
9.4
10
*
AAG99
NOMESCO Finland
Other stereotactic intracranial operation
+∞
9.4
9
*
AWB00
NOMESCO Finland
Reoperation for superficial infection in surgery of the nervous system
21.8
9.3
13
6
G23.9
ICD-10 Finland
Degenerative disease of basal ganglia, unspecified
9.6
9.3
18
19
L76
ICPC
Fracture: other
2.3
9.2
66
289
L84
ICD-10 Finland
Corns and callosities
2.3
9.2
68
302
F05.9
ICD-10 Finland
Delirium, unspecified
2.5
9.2
57
234
ZXE15
NOMESCO Finland
Procedure duration 120 to 149 minutes
3.7
9.2
28
76
M80.0
ICD-10 Finland
Postmenopausal osteoporosis with pathological fracture
2.5
9.1
54
217
H02AB02
ATC
dexamethasone; systemic
0.5
9.1
63
1335
S63.1
ICD-10 Finland
Dislocation of finger
3.2
9.1
35
111
R30.1
ICD-10 Finland
Vesical tenesmus
2.8
9.1
45
165
ZXH01
NOMESCO Finland
Procedure performed within operation theatre
15.7
9.0
14
9
N02BF01
ATC
gabapentin; oral
1.7
9.0
176
1091
G47.4
ICD-10 Finland
Narcolepsy and cataplexy
18.7
8.9
13
7
JDW98
NOMESCO Finland
Other transluminal endoscopic operation on stomach or duodenum
3.3
8.9
33
102
RF120, ,
NOMESCO Finland
3.6
8.8
28
78
H50.31
ICD-10 Finland
Intermittent exotropia
6.8
8.8
21
31
NF1AA
NOMESCO Finland
Hip X-ray examination
1.6
8.8
188
1190
K56.2
ICD-10 Finland
Volvulus
3.9
8.7
25
65
359
Kela drug reimbursment
Mirabegroni
4.8
8.6
19
40
N06BA04
ATC
methylphenidate; oral
4.8
8.6
19
40
ZXE17
NOMESCO Finland
Procedure duration 150 to 179 minutes
6.4
8.5
21
33
SPAT1306
SPAT
Counselling and guidance related to nutrition and weight management
1.6
8.5
224
1494
F02.3
ICD-10 Finland
Dementia in Parkinson disease
90.5
8.4
9
*
N06AX21
ATC
duloxetine; oral
1.7
8.4
174
1094
AA1DM
NOMESCO Finland
Very extensive MRI examination of brain with 3 Tesla magnet
4.9
8.4
18
37
TKC22
NOMESCO Finland
Catheterisation instruction
2.4
8.3
58
251
S01.8
ICD-10 Finland
Open wound of other parts of head
3.0
8.3
36
123
G30.1
ICD-10 Finland
Alzheimer disease with late onset
0.4
8.2
41
991
N18.9
ICD-10 Finland
Chronic kidney disease, unspecified
0.4
8.2
35
906
JX1LA
NOMESCO Finland
Kinetic X-ray of alimentary tract with pictures
11.7
8.1
14
12
ZXY02
NOMESCO Finland
Neuropsychologist
9.0
8.0
16
18
N02AA05
ATC
oxycodone; systemic
1.4
8.0
378
2837
NA3EA
NOMESCO Finland
Lumbar spine X-ray examination with flexion
2.3
7.9
57
251
J01CA08
ATC
pivmecillinam; oral
1.4
7.8
541
4322
G21.8
ICD-10 Finland
Other secondary parkinsonism
10.8
7.8
14
13
L75
ICPC
Fracture: femur
2.9
7.8
35
122
I87.2
ICD-10 Finland
Venous insufficiency (chronic)(peripheral)
1.6
7.7
192
1261
R41.0
ICD-10 Finland
Disorientation, unspecified
2.1
7.7
73
359
EBA05
NOMESCO Finland
Complicated extraction of tooth
1.4
7.7
328
2412
215
Kela drug reimbursment
Diabetes, non-insulin-treated
0.7
7.6
241
3377
E78.0
ICD-10 Finland
Pure hypercholesterolaemia
0.6
7.5
196
2856
R5140, ,
SPAT
3.0
7.5
32
108
SPAT1298
SPAT
Other function in accordance with nutritional therapy nomenclature
4.4
7.4
18
41
S06.0
ICD-10 Finland
Concussion
1.6
7.4
177
1152
IBC97
NOMESCO Finland
Other psychiatric aptitude assessment
80.4
7.4
8
*
214
Kela drug reimbursment
Severe and chronic narcolepsy
80.4
7.4
8
*
OAB73, ,
SPAT
6.5
7.4
18
28
M04AA01
ATC
allopurinol; systemic
0.6
7.4
128
2050
N06AX16
ATC
venlafaxine; oral
1.6
7.4
177
1153
M47.2
ICD-10 Finland
Other spondylosis with radiculopathy
1.8
7.4
112
646
F43.22
ICD-10 Finland
Adaptation disorder with mixed anxiety and depression
2.4
7.4
48
202
S01XA20
ATC
artificial tears and other indifferent preparations; ophthalmic
1.3
7.3
714
5983
N04C02, ,
ATC
+∞
7.3
7
*
EBA00
NOMESCO Finland
Extraction of tooth
1.3
7.3
539
4340
SPAT1244
SPAT
Occupational therapy
3.5
7.3
24
69
L01BC06
ATC
capecitabine; oral
0.2
7.2
9
383
N08
ICPC
Abnormal involuntary movements
7.3
7.2
16
22
SCA02
NOMESCO Finland
Preventive oral health care
1.7
7.2
119
705
S01.1
ICD-10 Finland
Open wound of eyelid and periocular area
2.3
7.2
54
243
R5599
NOMESCO Finland
Other rehabilitation service
2.3
7.1
52
231
ABC36
NOMESCO Finland
Decompression of lumbar nerve roots
1.8
7.1
101
572
T90
ICPC
Diabetes non-insulin dependent
0.7
7.1
257
3511
WX290
NOMESCO Finland
Other blockage of nerve
1.3
7.1
582
4758
S22.3
ICD-10 Finland
Fracture of rib
1.7
7.1
138
855
ZXE13
NOMESCO Finland
Procedure duration 90 to 119 minutes
2.5
7.0
41
164
XKD03
NOMESCO Finland
Urethral pressure profilometry
2.5
6.9
42
171
ZYC01
NOMESCO Finland
Remote contact by phone
1.8
6.8
91
505
N31.8
ICD-10 Finland
Other neuromuscular dysfunction of bladder
6.1
6.8
17
28
M41.8
ICD-10 Finland
Other forms of scoliosis
4.3
6.8
17
40
NE1AD
NOMESCO Finland
Pelvis and hip bones CT examination
2.2
6.7
55
256
R63.4
ICD-10 Finland
Abnormal weight loss
1.9
6.7
79
421
Y94.0
ICD-10 Finland
Accident at home
2.6
6.7
38
150
L21.9
ICD-10 Finland
Seborrhoeic dermatitis, unspecified
2.5
6.7
40
162
N32.82
ICD-10 Finland
Instability of the detrusor vesicae muscle
2.7
6.7
34
127
G23.2
ICD-10 Finland
Multiple system atrophy, parkinsonian type [MSA-P]
22.6
6.7
9
*
G55.2*M47.9
ICD-10 Finland
Nerve root and plexus compressions in spondylosis
2.6
6.6
36
139
SPAT1301
SPAT
No procedures
1.3
6.6
507
4095
SFA10
NOMESCO Finland
One-surface restoration
1.3
6.6
763
6518
Z43.5
ICD-10 Finland
Attention to cystostomy
3.6
6.6
21
59
R2130
NOMESCO Finland
Counselling and guidance which enhance independent living
1.6
6.6
138
871
M43.1
ICD-10 Finland
Spondylolisthesis
2.0
6.6
65
326
RF420, ,
NOMESCO Finland
3.0
6.5
28
95
I95.9
ICD-10 Finland
Hypotension, unspecified
2.5
6.5
40
164
ZXE11
NOMESCO Finland
Procedure duration 60 to 89 minutes
2.0
6.5
64
320
WD125
NOMESCO Finland
Demanding cystostatic therapy of methastized malignancy
0.2
6.5
10
448
RF410, ,
NOMESCO Finland
3.1
6.5
26
85
D12
ICPC
Constipation
1.9
6.5
75
398
Z3226
NOMESCO Finland
Physiotherapist
1.4
6.4
293
2178
M79.6
ICD-10 Finland
Pain in limb
1.3
6.4
663
5579
A10BA02
ATC
metformin; oral
0.7
6.4
333
4286
WX700
NOMESCO Finland
Respiratory and circulatory monitoring
1.4
6.3
273
2008
SPAT1149
SPAT
Suture or treatment of traumatic wound
1.5
6.3
214
1504
R60.9
ICD-10 Finland
Oedema, unspecified
1.7
6.3
100
586
R26.8
ICD-10 Finland
Other and unspecified abnormalities of gait and mobility
2.2
6.3
48
218
E11.9
ICD-10 Finland
Type 2 diabetes mellitus, without complications
0.7
6.2
290
3807
R39.1
ICD-10 Finland
Other difficulties with micturition
2.0
6.2
62
312
A08
ICPC
Swelling
1.7
6.2
110
664
S00.0
ICD-10 Finland
Superficial injury of scalp
2.2
6.2
50
232
PA2AD
NOMESCO Finland
CT angiography of brain
3.5
6.2
20
57
Z73.6
ICD-10 Finland
Limitation of activities due to disability
3.5
6.2
20
57
S62.3
ICD-10 Finland
Fracture of other metacarpal bone
2.3
6.1
43
188
Z02.7
ICD-10 Finland
Issue of medical certificate
1.7
6.1
118
729
T93
ICPC
Lipid disorder
0.4
6.1
37
824
S01
ICD-10 Finland
Open wound of head
2.9
6.1
28
99
S72.9
ICD-10 Finland
Fracture of femur, part unspecified
4.1
6.1
16
39
M20.4
ICD-10 Finland
Other hammer toe(s) (acquired)
1.8
6.1
82
458
G23.1
ICD-10 Finland
Progressive supranuclear ophthalmoplegia [Steele-Richardson-Olszewski]
8.6
6.1
12
14
TJD10
NOMESCO Finland
Insertion of other tube into stomach or duodenum
10.1
6.0
11
11
LabWAS
↥OMOP Concept
People with measurements
Mean N measurements
Mean measured value
(ID) Name
N Cases
N Controls
OR
-log10(p)
cases
controls
cases
controls
unit
-log10(p)
N cases
N controls
60
54
11.46
57.27
2.1
1.3
82.81
126.70
nmol/l
0.89
32
39
401
5945
0.58
19.82
4.0
4.2
4.84
8.95
mg/mmol
5.04
274
3752
398
5877
0.59
19.19
3.2
3.5
7.89
7.30
mmol/l
1.99
327
4898
43
100
4.38
17.15
2.8
2.3
—
—
—
0
0
710
5381
1.53
16.15
2.5
2.3
248.69
224.17
u/l
0.31
672
5081
674
5180
1.48
13.72
1.9
1.8
18.79
20.11
nmol/l
1.55
592
4308
1263
14049
0.66
13.51
5.2
6.4
2.55
2.54
mmol/l
0.01
1122
12805
1232
13741
0.67
12.92
4.5
5.5
4.39
4.45
mmol/l
1.20
1093
12591
1162
13104
0.68
12.90
3.9
4.6
1.12
1.28
mmol/l
20.67
1012
11770
1227
13639
0.68
11.87
4.6
5.4
1.45
1.44
mmol/l
0.68
1083
12383
452
5997
0.67
11.77
1.7
2.0
1.15
1.32
mmol/l
7.84
362
4913
295
1991
1.58
10.70
7.8
8.1
—
—
—
0
0
1168
10293
1.38
9.50
7.0
5.2
6095.92
1575.27
e6/l
0.65
24
166
1239
13583
0.72
9.13
6.5
7.3
39.25
40.38
mmol/mol
5.13
1113
12493
441
3342
1.42
8.90
1.9
1.8
1202.45
1171.72
nmol/l
0.28
327
2501
896
7642
1.34
8.59
2.4
2.3
86.10
94.06
pmol/l
7.53
571
4097
1001
11292
0.74
8.48
25.4
24.1
13.67
13.88
%
6.42
984
11121
475
3683
1.39
8.33
1.8
1.8
396.19
18212577.01
pmol/l
2.13
386
2998
578
4669
1.35
7.74
5.1
4.3
0.00
0.00
estimate
0.96
177
1582
782
6658
1.31
7.10
5.2
4.3
36.85
74.00
ng/l
1.89
655
5259
899
7826
1.30
6.81
5.0
6.8
1.20
1.21
mmol/l
0.46
808
7179
1288
13852
0.75
6.53
5.1
5.8
5.92
6.10
mmol/l
6.36
1114
12449
1000
11084
0.78
6.18
26.9
25.7
331.13
331.39
g/l
0.43
984
11004
1387
14731
0.74
6.12
10.9
13.4
17.65
25.47
u/l
84.76
1280
14218
917
8070
1.28
6.11
5.1
4.3
7.41
3.58
estimate
0.21
201
1807
17
34
5.04
5.87
2.4
2.4
—
—
—
0
0
902
7963
1.27
5.70
5.1
4.3
0.00
0.00
estimate
-0.00
199
1757
17
36
4.76
5.61
2.4
2.3
—
—
—
0
0
131
1953
0.64
5.52
2.8
4.2
36.24
21.57
ug/l
0.25
98
1640
399
3187
1.32
5.49
2.0
2.0
—
—
—
0
0
915
8122
1.26
5.40
5.2
4.3
0.00
0.20
estimate
0.57
190
1684
177
1240
1.47
5.32
2.0
1.7
—
—
—
0
0
1432
15078
0.75
5.27
32.0
29.4
6.62
6.90
e9/l
5.74
1394
14657
405
4946
0.77
5.18
2.6
3.2
28.10
35.44
u/l
3.84
377
4657
1433
15079
0.76
5.16
32.2
29.5
130.62
133.11
g/l
8.69
1409
14859
1433
15076
0.76
5.12
32.2
29.9
39.22
39.75
%
3.36
1410
14846
1433
15076
0.76
5.12
31.9
29.3
4.34
4.40
e12/l
5.56
1393
14652
1433
15074
0.76
5.09
31.8
29.3
91.77
91.83
fl
0.23
1409
14852
1433
15073
0.76
5.08
31.9
29.4
244.78
241.33
e9/l
1.23
1400
14708
20
513
0.38
4.71
1.2
1.6
0.09
0.34
mg/l
—
6
238
1280
13607
0.79
4.52
20.5
19.3
81.50
73.99
ml/min/173m2
43.44
1205
12761
101
1523
0.64
4.49
1.3
1.3
—
—
—
0
0
684
5963
1.24
4.47
5.2
4.4
0.00
0.10
estimate
0.79
170
1462
959
8667
1.23
4.43
5.3
7.6
1.21
1.21
mmol/l
0.05
809
7425
401
3302
1.28
4.29
1.8
1.7
1.28
1.52
mg/l
1.23
324
2614
1431
14990
0.78
4.26
27.5
26.0
72.98
83.89
umol/l
50.22
1410
14777
482
4066
1.25
4.20
2.5
2.6
—
—
—
0
0
426
3554
1.26
4.07
5.4
4.5
1.02
1.02
kg/l
3.14
299
2401
781
6994
1.21
3.72
2.6
2.4
—
—
—
0
0
163
1212
1.38
3.58
5.2
6.6
25.79
24.39
mmol/l
8.22
154
1163
23
100
2.32
3.43
1.1
1.1
2.22
4.34
nmol/l
—
6
24
810
7318
1.19
3.41
2.9
3.0
—
—
estimate
—
0
0
133
965
1.41
3.38
1.6
1.5
—
—
—
0
0
97
667
1.48
3.29
3.6
4.2
25.49
24.99
mmol/l
0.99
85
612
532
4639
1.21
3.26
2.5
2.4
2.88
2.94
mg/l
0.24
424
3974
96
664
1.47
3.17
2.0
1.8
—
—
—
0
0
102
721
1.44
3.02
2.0
2.0
—
—
—
0
0
291
2405
1.25
2.97
1.9
1.9
—
—
—
0
0
21
94
2.25
2.97
1.3
2.0
—
—
—
0
0
468
4076
1.20
2.86
4.6
3.9
0.00
0.23
estimate
0.66
161
1377
1423
14774
0.82
2.77
26.1
23.8
3.96
4.01
mmol/l
8.70
1397
14447
1421
14755
0.82
2.77
26.0
23.6
139.89
139.61
mmol/l
4.21
1393
14448
133
1744
0.74
2.76
3.6
7.1
10.10
11.01
mmol/l
0.80
125
1666
36
612
0.58
2.73
1.4
1.7
6.55
7.69
iu/ml
0.19
13
145
182
2274
0.78
2.65
3.2
4.3
235.55
249.04
u/l
0.73
160
2160
21
414
0.50
2.63
1.3
1.2
1.98
5.75
u/ml
—
6
59
85
1182
0.71
2.57
3.9
3.0
9.83
10.87
g/l
1.17
75
1087
377
4331
0.84
2.47
2.3
3.0
321.29
357.79
umol/l
9.33
311
3740
1030
9646
1.16
2.46
4.7
5.3
6.41
6.87
mmol/l
17.07
995
9233
245
2033
1.24
2.43
4.6
5.3
34.74
33.14
%
1.40
154
1289
0
65
0.00
2.42
0.0
2.6
—
39931.00
—
0
12
100
1338
0.73
2.40
1.4
1.8
1.47
1.61
%
0.76
82
1115
15
320
0.46
2.38
1.7
1.5
34.74
31.63
g/l
0.46
15
288
11
256
0.43
2.21
2.0
1.7
29.62
24.02
ug/l
0.15
11
250
111
848
1.33
2.14
1.3
1.4
94.83
55.58
au/ml
—
6
66
194
2342
0.81
2.12
1.3
1.3
5.39
13.95
u/ml
2.12
74
821
266
2272
1.20
1.99
4.2
7.2
1.83
0.87
mmol/l
4.72
225
1860
266
2278
1.20
1.94
4.2
7.2
5.27
5.09
kpa
3.38
252
2192
266
2279
1.20
1.93
4.2
7.2
12.20
11.87
kpa
0.45
251
2197
135
1078
1.27
1.90
3.1
3.8
2.29
2.07
mmol/l
0.29
106
810
29
173
1.69
1.90
1.2
1.3
216121.61
139901.15
e6/l
0.15
23
117
16
79
2.03
1.85
1.3
1.4
—
—
—
0
0
126
1567
0.79
1.81
3.6
3.1
182.96
241.27
ng/l
0.96
116
1448
210
2472
0.83
1.79
1.3
1.3
22.94
36.06
iu/ml
1.98
57
786
53
745
0.70
1.78
1.2
1.2
33.12
137.23
u/ml
7.20
22
258
645
5944
1.13
1.77
3.1
3.3
1085.23
1709.49
ng/l
5.93
551
5167
63
853
0.73
1.70
1.9
2.1
3.17
3.48
ratio
1.50
49
697
25
406
0.61
1.69
1.5
1.5
—
—
—
0
0
20
343
0.58
1.67
1.1
1.3
—
—
—
0
0
(3020427) Coagulation factor X inhibitor [Units/volume] in Platelet poor plasma by Coagulation assay
47
666
0.70
1.67
2.8
2.5
0.45
0.35
iu/ml
0.51
27
364
301
3409
0.86
1.63
4.4
4.3
35.43
419.07
ng/l
14.52
245
2915
216
1847
1.19
1.63
2.1
2.6
60.71
68.88
e9/l
3.66
160
1373
117
939
1.26
1.62
2.5
2.6
13.53
18.37
au/ml
—
7
66
151
1250
1.23
1.59
3.5
4.0
5.28
5.16
kpa
1.17
140
1201
531
4868
1.13
1.56
4.1
3.5
0.39
0.46
e6/l
0.48
408
3692
12
234
0.51
1.56
1.3
1.2
225.67
273.24
u/ml
—
6
125
212
2458
0.84
1.54
3.3
5.9
1.00
1.04
mmol/l
1.19
190
2279
20
115
1.75
1.52
1.3
1.4
—
—
—
0
0
26
406
0.64
1.51
1.3
1.2
—
—
—
0
0
440
3994
1.13
1.51
3.1
2.8
4.53
4.90
e6/l
0.37
409
3657
0
45
0.00
1.50
0.0
1.3
—
9.16
—
0
45
20
116
1.73
1.49
1.3
1.4
—
—
—
0
0
62
462
1.35
1.48
1.9
1.6
10099.05
15657.49
e6/l
0.77
44
320
29
439
0.66
1.47
1.3
1.5
1.36
16.66
iu/ml
—
8
81
7
151
0.46
1.43
1.6
1.6
—
—
—
0
0
6
22
2.73
1.43
1.0
1.0
—
—
—
0
0
33
480
0.68
1.39
3.0
3.4
0.88
0.84
nmol/l
0.15
22
392
15
262
0.57
1.38
1.5
2.6
—
431.95
—
0
21
16
274
0.58
1.37
1.2
1.3
—
18.55
—
0
6
9
41
2.20
1.37
2.2
1.7
62.78
238.56
nmol/24h
—
9
41
6
23
2.61
1.37
1.0
1.0
—
—
—
0
0
43
593
0.72
1.35
1.7
1.9
3.10
3.45
mmol/l
1.36
32
438
162
1896
0.84
1.33
2.3
2.7
8.79
8.87
umol/l
0.01
138
1689
190
1638
1.18
1.33
2.3
2.5
5.17
7.34
ug/l
1.78
134
1446
64
489
1.32
1.33
1.7
1.6
—
—
—
0
0
254
2242
1.15
1.32
2.0
1.9
—
—
—
0
0
605
5636
1.11
1.32
4.2
3.7
23.51
93.04
e6/l
4.78
478
4420
28
184
1.53
1.32
2.7
2.7
—
—
—
0
0
15
257
0.58
1.30
1.1
1.1
—
—
—
0
0
155
1321
1.19
1.25
1.8
1.6
—
—
—
0
0
48
641
0.74
1.25
1.2
1.8
39.62
38.51
u/l
0.14
40
559
232
2044
1.16
1.25
4.3
7.5
95.69
95.25
%
0.62
221
1981
147
1721
0.84
1.23
1.8
2.2
0.19
0.20
g/l
0.63
137
1600
15
85
1.77
1.23
1.3
1.1
—
—
—
0
0
108
1298
0.82
1.20
2.9
3.1
75.55
61.34
ml/min/173m2
3.24
53
582
33
465
0.70
1.20
1.2
1.7
—
—
—
0
0
656
6165
1.10
1.18
4.9
4.3
145.35
122.90
e6/l
0.26
486
4546
6
128
0.47
1.16
1.2
1.2
7.50
7.50
mmol/l
—
6
107
235
2636
0.88
1.13
1.4
1.5
2.22
2.73
g/l
4.64
115
1530
14
80
1.76
1.13
1.4
1.4
—
—
—
0
0
14
80
1.76
1.13
1.4
1.4
—
—
—
0
0
52
397
1.32
1.12
2.1
1.6
—
—
—
0
0
728
6893
1.09
1.11
2.4
2.4
73.60
79.04
nmol/l
6.85
624
6064
805
7667
1.09
1.06
3.8
5.2
35.15
34.77
g/l
1.11
739
7164
362
3940
0.90
1.06
3.1
3.5
0.66
0.79
ug/l
4.29
258
2755
23
335
0.68
1.03
1.1
1.3
—
384.00
—
0
30
60
474
1.27
1.02
1.5
1.6
18.40
22.66
u/ml
—
7
81
23
334
0.68
1.02
1.1
1.3
—
365.00
—
0
8
31
426
0.72
1.01
2.1
2.4
11.35
93.96
ug/min
3.68
15
253
31
225
1.38
0.94
1.6
2.5
37.00
20.74
mg/l
—
8
85
873
8379
1.08
0.92
13.0
18.4
1.26
1.34
inr
4.02
723
7039
22
315
0.69
0.92
1.1
1.1
—
3.33
—
0
26
74
894
0.82
0.91
5.3
3.9
1.02
1.02
ratio
1.61
62
823
24
168
1.43
0.90
1.5
1.3
—
—
—
0
0
13
206
0.63
0.89
6.9
4.0
—
—
—
0
0
6
30
2.00
0.87
1.0
1.4
4.45
2.49
umol/l
—
6
23
331
3057
1.10
0.85
3.8
3.2
1.89
1.07
e6/l
0.85
180
1710
614
5827
1.08
0.85
2.6
3.6
2.34
2.35
mmol/l
0.62
541
5219
23
321
0.71
0.85
1.3
1.4
0.78
0.82
nmol/l
0.09
15
257
12
190
0.63
0.83
1.2
1.8
—
—
—
0
0
386
3598
1.09
0.82
2.6
3.1
2.45
2.46
mmol/l
1.81
337
3225
699
6677
1.08
0.82
3.1
3.1
139.56
152.13
ug/l
0.65
617
6105
6
32
1.88
0.82
1.5
1.1
—
—
—
0
0
10
165
0.60
0.82
1.2
1.1
—
48.91
—
0
11
165
1471
1.13
0.80
2.6
2.6
0.63
0.53
e6/l
0.18
156
1415
23
317
0.72
0.80
1.2
1.8
—
—
—
0
0
95
1104
0.85
0.79
6.8
9.4
16.17
15.78
%
0.73
89
1067
0
24
0.00
0.79
0.0
11.6
—
5.16
—
0
24
11
66
1.67
0.78
2.9
1.8
6.79
13.19
nmol/l
0.40
11
57
7
125
0.56
0.77
1.0
1.1
—
—
—
0
0
10
161
0.62
0.75
1.8
2.0
2.92
4.65
mg/l
—
10
156
36
458
0.78
0.74
1.2
1.6
—
—
—
0
0
844
8738
0.94
0.73
7.1
9.7
4.18
4.27
e9/l
0.53
722
7545
6
109
0.55
0.72
1.2
1.2
—
—
—
0
0
29
220
1.32
0.71
2.0
7.1
7.40
7.58
mmol/l
0.10
24
188
14
206
0.68
0.71
1.0
1.0
—
—
—
0
0
5
26
1.93
0.70
1.2
1.8
108.60
99.00
%
—
5
26
640
6676
0.94
0.68
5.2
6.0
2.16
3.93
ug/l
2.09
564
5961
17
119
1.43
0.67
1.0
1.1
115.29
102.68
pmol/l
0.58
17
119
7
43
1.63
0.67
1.1
1.1
—
—
—
0
0
60
710
0.84
0.65
3.4
2.7
—
—
—
0
0
12
178
0.67
0.65
1.1
1.8
—
—
—
0
0
53
442
1.21
0.63
1.8
2.3
123.39
127.70
g/l
0.60
44
353
1386
14083
0.93
0.63
22.4
19.4
27.65
27.37
mg/l
0.11
1212
11917
24
313
0.76
0.62
1.4
1.3
—
—
—
0
0
58
490
1.19
0.61
1.5
1.4
—
—
—
0
0
47
389
1.21
0.61
1.8
2.7
25.31
33.32
umol/l
3.18
39
342
140
1548
0.90
0.60
2.7
2.4
54.44
38.59
u/l
0.27
115
1295
0
22
0.00
0.59
0.0
1.1
—
—
—
0
0
514
5376
0.94
0.59
4.4
4.9
20.72
21.71
%
0.99
266
2865
22
286
0.77
0.57
1.4
1.4
—
—
—
0
0
6
36
1.67
0.56
1.2
1.1
—
—
—
0
0
5
89
0.56
0.56
1.0
1.2
—
—
—
0
0
10
65
1.54
0.55
1.3
1.2
—
—
—
0
0
10
148
0.67
0.55
1.2
1.1
—
59.00
—
0
5
11
159
0.69
0.54
2.0
1.4
9.64
13.68
u/l
2.27
11
150
45
535
0.84
0.54
1.0
1.1
—
—
—
0
0
18
238
0.75
0.53
1.1
1.6
—
—
—
0
0
98
875
1.13
0.52
1.9
1.9
1.97
1.81
ug/l
0.06
78
767
13
179
0.72
0.50
1.2
1.1
—
—
—
0
0
70
614
1.15
0.49
1.2
1.3
—
—
—
0
0
198
1841
1.08
0.49
5.1
3.7
—
—
—
0
0
112
1235
0.90
0.48
1.3
1.4
—
—
—
0
0
7
47
1.49
0.47
1.1
1.1
—
—
—
0
0
40
337
1.19
0.46
1.5
1.3
8.70
57.36
e6/l
1.17
30
253
5
82
0.61
0.45
1.6
1.4
0.60
2.86
u/field
—
5
58
152
1403
1.09
0.45
3.2
4.1
1.23
1.22
mmol/l
0.20
127
1197
22
174
1.27
0.45
1.8
1.7
—
—
—
0
0
109
1196
0.91
0.44
4.4
8.7
25.36
24.16
mmol/l
3.68
104
1170
7
51
1.37
0.44
1.1
1.2
—
—
—
0
0
202
1891
1.08
0.44
4.9
7.9
121.56
120.57
g/l
0.29
194
1849
9
130
0.69
0.43
1.1
1.1
—
—
—
0
0
111
1213
0.91
0.42
2.9
3.1
128.37
127.32
g/l
0.23
106
1177
1106
10864
1.05
0.42
4.2
4.2
15.34
15.06
pmol/l
2.96
972
9755
40
341
1.18
0.42
1.5
1.4
275.39
587.72
e6/l
0.40
33
267
32
381
0.84
0.42
1.4
1.7
2.45
5.43
mg/l
1.23
26
303
297
2825
1.06
0.41
4.1
3.4
2.32
1.90
e6/l
0.37
143
1467
0
17
0.00
0.40
0.0
1.1
—
0.10
—
0
8
0
17
0.00
0.40
0.0
1.1
—
—
—
0
0
18
141
1.28
0.40
1.7
1.8
—
—
—
0
0
109
999
1.10
0.39
2.3
2.6
0.64
0.62
%
0.47
109
993
154
1434
1.08
0.39
1.9
2.2
370.91
380.73
nmol/l
0.24
135
1308
28
334
0.84
0.38
1.3
1.4
—
—
—
0
0
26
312
0.83
0.38
3.4
4.2
5.50
1.51
%
0.91
20
280
25
206
1.22
0.38
1.5
1.3
0.96
0.35
nmol/l
2.01
14
15
8
114
0.70
0.37
1.1
1.1
—
—
—
0
0
33
386
0.85
0.37
1.4
1.4
—
—
—
0
0
89
974
0.91
0.36
1.6
1.8
1.58
1.53
g/l
0.16
72
843
60
671
0.89
0.36
2.5
3.3
26.23
25.00
mmol/l
2.70
60
663
9
71
1.27
0.36
1.1
1.4
156.46
153.52
pmol/l
—
9
71
5
78
0.64
0.35
1.0
4.2
13.02
13.35
%
—
5
78
16
126
1.27
0.35
1.8
2.2
7.42
8.30
mmol/l
0.77
16
126
6
46
1.31
0.33
1.8
2.0
29.22
196.54
ug/l
—
6
39
(3016894) Varicella zoster virus DNA [Presence] in Cerebral spinal fluid by NAA with probe detection
11
83
1.33
0.32
1.5
1.2
—
—
—
0
0
43
380
1.13
0.31
2.0
2.8
15.55
16.03
%
0.46
43
371
12
153
0.78
0.30
1.0
1.1
—
1.60
—
0
17
530
5158
1.04
0.30
2.5
2.7
55.08
77.55
u/l
0.80
479
4743
52
467
1.12
0.30
3.2
3.5
2.04
1.66
index
0.16
25
253
7
55
1.27
0.30
1.3
1.1
—
—
—
0
0
29
335
0.86
0.29
1.4
1.4
—
—
—
0
0
66
722
0.91
0.29
2.0
3.7
45.05
61.02
mg/l
0.70
56
619
66
722
0.91
0.29
2.0
3.7
22.84
83.54
mg/l
2.09
56
621
8
107
0.75
0.29
1.1
1.1
—
—
—
0
0
8
107
0.75
0.29
1.1
1.1
—
—
—
0
0
131
1392
0.94
0.29
2.5
4.0
73.02
97.25
ng/l
3.50
92
1195
424
4116
1.04
0.28
4.0
4.3
86.08
84.68
%
0.61
417
4030
11
140
0.78
0.28
1.0
1.1
0.52
1.07
u/ml
—
5
80
28
242
1.16
0.28
1.0
1.3
11.17
9.83
u/l
0.26
23
191
46
511
0.90
0.27
1.3
1.2
0.24
0.81
u/ml
—
5
43
8
66
1.21
0.26
1.0
1.1
—
—
—
0
0
13
104
1.25
0.26
1.5
1.4
—
—
—
0
0
13
104
1.25
0.26
1.5
1.4
—
—
—
0
0
5
74
0.67
0.26
9.0
5.4
—
83.69
—
0
13
12
149
0.80
0.25
1.2
1.6
—
—
—
0
0
11
138
0.80
0.25
1.2
1.1
95.45
96.22
%
0.04
11
130
19
224
0.85
0.25
1.4
1.6
—
—
—
0
0
1099
11120
0.97
0.25
4.3
4.6
11.79
14.09
mm/h
6.46
994
10287
181
1893
0.95
0.24
2.8
3.6
2.57
1.93
mmol/l
1.74
154
1616
42
465
0.90
0.24
2.7
3.2
7.97
7.82
kpa
0.27
42
453
26
227
1.15
0.23
1.2
1.5
—
—
—
0
0
83
775
1.07
0.23
2.7
3.5
4.42
4.37
pmol/l
0.22
77
686
46
505
0.91
0.23
2.0
1.7
—
—
—
0
0
61
658
0.92
0.21
1.8
3.5
1.94
3.68
ratio
1.12
41
386
0
11
0.00
0.21
0.0
1.0
—
—
—
0
0
0
10
0.00
0.21
0.0
1.1
—
—
—
0
0
0
12
0.00
0.21
0.0
1.1
—
—
—
0
0
8
103
0.78
0.21
1.1
1.1
—
—
—
0
0
8
104
0.77
0.21
1.1
1.1
—
—
—
0
0
0
13
0.00
0.21
0.0
1.1
—
—
—
0
0
0
13
0.00
0.21
0.0
1.0
—
—
—
0
0
49
532
0.92
0.20
1.2
1.3
—
—
—
0
0
0
14
0.00
0.20
0.0
1.1
—
—
—
0
0
889
9002
0.98
0.20
3.1
3.4
44.02
56.74
u/l
2.19
803
8284
9
113
0.80
0.20
1.4
1.5
—
—
—
0
0
11
90
1.22
0.19
1.7
2.3
—
—
—
0
0
45
414
1.09
0.19
1.5
1.6
—
—
—
0
0
55
511
1.08
0.19
1.5
1.4
279.92
274.85
ug/g
0.07
39
317
55
591
0.93
0.18
2.5
2.4
0.02
0.00
g/l
0.49
49
518
78
827
0.94
0.18
1.3
1.3
187.19
214.37
u/ml
0.18
72
760
301
2932
1.03
0.18
1.3
1.3
1.29
1.53
u/ml
0.23
73
741
85
898
0.94
0.18
3.1
3.3
25.88
25.17
mmol/l
1.41
80
869
188
1944
0.96
0.17
2.7
3.6
5.87
5.83
kpa
0.21
181
1889
7
62
1.13
0.17
2.1
2.8
5.41
4.91
kpa
—
7
62
7
62
1.13
0.17
2.1
2.8
8.57
10.14
kpa
—
7
62
7
63
1.11
0.17
1.4
1.0
—
—
—
0
0
856
8656
0.98
0.17
4.2
6.8
11.52
12.17
umol/l
0.86
800
8247
22
196
1.12
0.16
1.4
1.4
—
—
—
0
0
1302
13104
0.98
0.16
5.4
5.3
1.91
2.03
mu/l
2.86
1153
11857
8
70
1.14
0.16
1.0
1.4
28.13
29.30
umol/l
—
8
64
167
1615
1.04
0.16
2.6
2.9
4.32
4.47
kpa
0.55
162
1567
6
80
0.75
0.15
1.3
2.0
21.17
16.49
nmol/l
—
6
71
10
83
1.21
0.15
1.0
1.1
—
—
—
0
0
22
197
1.12
0.15
1.4
1.4
—
—
—
0
0
19
169
1.13
0.14
2.2
3.3
14.83
10.99
index
—
6
95
7
90
0.78
0.14
1.1
1.8
—
—
—
0
0
7
90
0.78
0.14
1.1
1.8
—
—
—
0
0
7
90
0.78
0.14
1.1
1.8
—
—
—
0
0
7
90
0.78
0.14
1.1
1.8
—
—
—
0
0
17
191
0.89
0.14
1.3
1.2
3.38
3.80
u/ml
—
8
61
78
817
0.95
0.13
2.2
2.4
4.12
4.20
g/l
0.34
68
744
78
817
0.95
0.13
2.2
2.4
6.91
7.44
g/l
2.17
67
743
8
97
0.82
0.13
2.6
3.8
—
—
—
0
0
11
128
0.86
0.13
1.4
1.4
—
—
—
0
0
78
816
0.95
0.13
2.2
2.4
3.56
3.77
g/l
0.79
68
742
9
109
0.82
0.13
1.4
1.5
—
—
—
0
0
21
190
1.11
0.12
1.4
1.5
—
—
—
0
0
21
190
1.11
0.12
1.4
1.5
—
—
—
0
0
303
2973
1.02
0.12
2.3
3.2
0.83
0.82
mmol/l
1.75
277
2808
11
127
0.87
0.12
1.2
1.1
—
—
—
0
0
20
181
1.11
0.12
1.3
1.4
—
—
—
0
0
19
172
1.11
0.11
1.3
1.5
23.76
33.53
ng/l
0.63
19
172
23
211
1.09
0.11
2.5
2.6
1.50
0.17
mmol/l
2.17
23
205
39
367
1.06
0.11
3.7
3.8
32.28
28.38
mg/l
0.21
27
256
21
192
1.09
0.10
1.4
1.4
—
—
—
0
0
5
45
1.11
0.09
1.0
1.0
93.80
99.92
%
—
5
37
16
176
0.91
0.09
1.1
1.1
119.31
115.61
%
0.25
16
163
90
872
1.03
0.09
4.9
4.7
1.47
1.58
%
0.59
82
829
14
155
0.90
0.09
1.1
1.6
—
—
—
0
0
14
155
0.90
0.09
1.1
1.6
—
—
—
0
0
14
155
0.90
0.09
1.1
1.6
—
—
—
0
0
152
1552
0.98
0.08
2.0
2.2
184.45
151.97
ug/g
0.60
121
1238
5
63
0.79
0.08
3.0
2.9
23.00
31.03
umol/l
—
5
41
265
2689
0.98
0.08
2.3
2.8
21.09
22.06
%
0.55
236
2499
30
283
1.06
0.08
1.3
1.4
—
—
—
0
0
21
195
1.08
0.08
1.4
1.4
—
—
—
0
0
291
2872
1.02
0.07
2.2
2.7
2.29
2.25
g/l
0.58
255
2649
37
388
0.95
0.07
6.9
6.7
106.13
105.46
mmol/l
0.41
30
352
47
451
1.04
0.07
1.5
1.3
—
—
—
0
0
15
137
1.10
0.07
1.1
1.3
—
—
—
0
0
8
75
1.07
0.07
1.3
2.3
692.00
1370.19
u/ml
—
8
75
135
1378
0.98
0.07
1.3
1.4
—
—
—
0
0
274
2776
0.98
0.07
2.2
2.0
29.87
29.79
s
0.07
267
2695
127
1297
0.98
0.07
1.9
2.3
13.24
12.91
nmol/l
0.18
112
1140
31
294
1.06
0.07
1.9
2.0
1.75
1.69
mmol/l
0.09
31
285
70
721
0.97
0.07
2.2
2.5
9.27
10.70
g/l
3.14
59
641
20
214
0.93
0.07
4.0
4.1
63.00
57.15
%
0.85
14
188
9
88
1.02
0.07
1.1
1.2
—
—
—
0
0
9
88
1.02
0.07
1.1
1.2
—
—
—
0
0
403
3992
1.01
0.07
4.0
3.4
0.00
0.03
0.99
12
129
22
234
0.94
0.06
1.1
1.2
0.82
0.91
g/l
1.03
22
234
17
183
0.93
0.06
1.3
1.2
1.14
4.92
u/ml
—
7
87
17
183
0.93
0.06
1.2
1.3
199.09
266.43
pmol/l
0.53
11
156
9
100
0.90
0.06
1.4
1.9
—
—
—
0
0
50
483
1.04
0.06
1.8
1.6
—
—
—
0
0
32
334
0.96
0.05
1.6
1.9
6.36
22.37
iu/l
—
10
128
43
444
0.97
0.04
1.7
1.5
—
—
—
0
0
29
278
1.04
0.04
1.4
1.3
—
—
—
0
0
19
201
0.94
0.04
1.2
1.4
274.50
276.11
mosm/kgh2o
0.13
14
145
16
151
1.06
0.03
2.2
2.0
2.75
1.56
u/field
—
8
81
170
1684
1.01
0.03
2.0
2.8
65.65
66.34
g/l
0.59
140
1551
169
1705
0.99
0.03
3.9
7.1
1.21
1.39
mmol/l
1.62
163
1673
40
391
1.02
0.02
1.2
1.2
—
—
—
0
0
72
710
1.01
0.02
2.2
2.6
0.23
1.46
g/l
6.55
57
611
1192
11906
1.00
0.01
6.2
8.7
81.77
81.77
u/l
0.00
1092
11231
75
759
0.99
0.01
2.2
2.5
2.90
2.99
g/l
0.31
64
685
40
393
1.02
0.01
1.2
1.2
—
—
—
0
0
18
186
0.97
0.00
1.1
1.2
0.62
0.66
ratio
—
9
40
15
151
0.99
0.00
1.1
1.3
—
—
—
0
0
37
365
1.01
0.00
1.4
1.4
—
—
—
0
0
37
365
1.01
0.00
1.4
1.4
—
—
—
0
0
11
106
1.04
0.00
1.3
1.8
74.36
109.37
ng/l
1.58
11
106
60
602
1.00
0.00
2.3
2.4
0.02
0.02
g/l
0.07
54
539
306
3058
1.00
0.00
2.3
2.8
11.74
12.24
umol/l
0.60
274
2840
20
203
0.99
0.00
1.9
1.6
46.80
63.91
%
1.19
14
128
20
197
1.02
0.00
1.4
1.5
—
—
—
0
0
22
217
1.01
0.00
1.1
1.2
1.51
1.54
g/l
0.24
22
217
6
68
0.88
0.00
1.3
1.2
—
70.22
%
—
0
9
6
68
0.88
0.00
1.2
2.0
—
—
—
0
0
6
68
0.88
0.00
1.2
2.0
—
—
—
0
0
0
8
0.00
-0.00
0.0
1.0
—
—
—
0
0
0
5
0.00
-0.00
0.0
1.0
—
7.66
—
0
5
0
7
0.00
-0.00
0.0
1.6
—
—
—
0
0
7
79
0.89
-0.00
1.1
1.1
—
—
—
0
0
0
7
0.00
-0.00
0.0
1.0
—
—
—
0
0
0
5
0.00
-0.00
0.0
1.0
—
—
—
0
0
0
5
0.00
-0.00
0.0
1.0
—
1745.20
—
0
5
8
86
0.93
-0.00
1.0
1.0
—
—
—
0
0
6
69
0.87
-0.00
1.3
2.0
—
—
—
0
0
8
87
0.92
-0.00
1.4
1.4
92.38
90.14
umol/l
—
8
87
0
7
0.00
-0.00
0.0
1.1
—
—
—
0
0
0
6
0.00
-0.00
0.0
1.0
—
—
—
0
0
9
94
0.96
-0.00
1.9
3.8
1.44
1.02
%
—
9
94
6
61
0.98
-0.00
1.2
1.1
—
—
—
0
0
0
5
0.00
-0.00
0.0
5.2
—
377.80
—
0
5
0
7
0.00
-0.00
0.0
1.1
—
—
—
0
0
0
5
0.00
-0.00
0.0
8.4
—
74.80
—
0
5
0
5
0.00
-0.00
0.0
3.0
—
—
—
0
0
7
73
0.96
-0.00
1.0
1.2
—
—
—
0
0
0
5
0.00
-0.00
0.0
1.0
—
—
—
0
0
0
5
0.00
-0.00
0.0
1.0
—
—
—
0
0
0
8
0.00
-0.00
0.0
1.0
—
—
—
0
0
Mortality – FinRegistry
↥This endpoint is excluded from FinRegistry analyses (omitted endpoint).
Relationships between endpoints
↥Index endpoint: PDMED_SELEGILINE – Use of selegiline
GWS hits: -
This endpoint is excluded from FinRegistry analyses (omitted endpoint).